Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?

P. Menichini, P. Monti, A. Speciale, G. Cutrona, S. Matis, F. Fais, E. Taiana, A. Neri, R. Bomben, M. Gentile, V. Gattei, M. Ferrarini, F. Morabito, G. Fronza

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number98
JournalCells
Volume10
Issue number1
DOIs
Publication statusPublished - 2021

Keywords

  • CLL
  • hematological malignancies
  • leukemia
  • mutant P53
  • PRIMA-1/APR246

Cite this